Bus drivers supplemented with the anti-oxidant, N-acetyl cysteine (NAC) for 4 weeks show reduced lung oxidative stress and improved lung function Source: Annual Congress 2007 - Acute and chronic effects of air pollution Year: 2007
The effects of antioxidant therapy on lung clearance, pulmonary function test and oxidant stress in patients with COPD Source: Eur Respir J 2002; 20: Suppl. 38, 258s Year: 2002
The extent of exercise-induced oxidative stress is minimized by erdosteine, but not placebo, in severe COPD Source: Annual Congress 2010 - New treatments for asthma and COPD Year: 2010
COPD and oxidative stress: NAC‘s (n-acetylcysteine) effects Source: Annual Congress 2007 - Mechanisms and new treatments of COPD Year: 2007
The influence of N-acetylcysteine on oxidative stress in patients with COPD Source: Annual Congress 2010 - Novel insights into the pathophysiology of asthma and COPD Year: 2010
Increasing oxidative stress and inflammation in patients with exacerbated chronic obstructive pulmonary disease (COPD) and their association with lung function Source: Annual Congress 2012 - The smoking gun in COPD biology Year: 2012
Increased oxidative stress in patients with chronic obstructive pulmonary disease (COPD) as measured by redox status of plasma coenzyme Q10 Source: Eur Respir J 2006; 28: Suppl. 50, 428s Year: 2006
Low dose of sodium hypochlorite impair lung function, inflammation and oxidative stress of naïve mice Source: International Congress 2019 – Novel insights from in vitro and in vivo models of lung disease Year: 2019
Comparison of oxidative stress markers in 3 matrices (EBC, blood and urine) in patients with occupational lung fibrosis and control subjects Source: Annual Congress 2010 - Occupational and environmental exposures and respiratory disease Year: 2010
Roflumilast, an oral, once-daily PDE4 inhibitor, improves lung function and reduces exacerbation rates in patients with COPD Source: Eur Respir J 2004; 24: Suppl. 48, 21s Year: 2004
Impact of bisphosphonate (BP) use on lung function decline and treatment response in patients (pts) with idiopathic pulmonary fibrosis (IPF) Source: Virtual Congress 2020 – News on diagnosis and therapy of idiopathic pulmonary fibrosis Year: 2020
Overexpression of RAGE in lungs of patients with COPD: A contributor to oxidative stress in COPD Source: Annual Congress 2011 - Recent developments in COPD Year: 2011
Effect of pulmonary rehabilitation on erythrocyte oxidative stress and antioxidants in COPD patients Source: Annual Congress 2012 - The best posters on physical inactivity, muscle dysfunction and exercise intolerance Year: 2012
Effect of oxidative stress and serum antioxidant activity on the incidence of chronic lung disease (bronchopulmonary dysplesia) in premature infants Source: Eur Respir J 2004; 24: Suppl. 48, 621s Year: 2004
Effect of oxidative stress and serum antioxidant activity on the incidence of chronic lung disease (bronchopulmonary dysplesia) in premature infants Source: Eur Respir J 2002; 20: Suppl. 38, 283s Year: 2002
Effectiveness of N-acetylcysteine in correction of oxidative stress in combined therapy in patients with severe bronchial asthma Source: Annual Congress 2007 - Traditional and novel approaches to assess and achieve asthma control Year: 2007
Pre-treatment lung function decline stabilizes up to 3 year after targeted lung denervation in COPD Source: Virtual Congress 2020 – The hot and cold of interventional pulmonology Year: 2020
Plasma level of total hydroperoxide (TH) as a marker of oxidative stress seems to be a useful index of disease severity in patients with idiopathic pulmonary fibrosis (IPF) Source: Eur Respir J 2005; 26: Suppl. 49, 335s Year: 2005
Rosuvastatin effects on systemic inflammation, oxidative stress and antioxidants in patients with chronic obstructive pulmonary disease Source: International Congress 2016 – COPD diagnosis and management Year: 2016
Pulmonary function, oxidative stress and inflammatory markers in LPS-induced acute lung injury: Differential effects of atorvastatin, pravastatin and simvastatin Source: Annual Congress 2012 - Cell culture and animal models of lung disease Year: 2012